Predictors of Smoking Cessation in Patients With Rheumatoid Arthritis in Two Cohorts: Most Predictive Health Care Factors

Abstract

Objective Recognizing smoking as a risk factor for rheumatoid arthritis (RA) severity, the present study was undertaken to evaluate patient‐ and health care–level predictors of smoking cessation in patients with RA to guide implementation of smoking cessation interventions. Methods Electronic health record data from 2 health systems were abstracted for patients with at least 2 International Classification of Disease diagnosis codes for RA between 2005 and 2016. Patients missing smoking statuses or with <6 months of follow‐up were excluded. Multivariable logistic regression was used to determine predictors of smoking cessation. Results Among 3,577 patients with RA, 507 smoked at baseline, and 29% quit over a median of 4.75 years. Black male patients, ages 40–59 years and enrolled in Medicaid, were significantly more likely to be baseline smokers; however, none of these factors predicted cessation. Instead, patients new to rheumatology care were 60% more likely to quit (adjusted odds ratio [ORadj] 1.60 [95% confidence interval (95% CI) 1.02–2.50]), and patients in the rural community health system were 66% more likely to quit (ORadj 1.66 [95% CI 1.03–2.69]). Seropositive patients were 43% less likely to quit smoking (ORadj 0.57 [95% CI 0.35–0.91]). Conclusion Health care factors, including health system and being new to rheumatology care, were more predictive of smoking cessation in patients with RA than patient sociodemographic factors, suggesting an important role for health system cessation efforts for patients with RA. Seropositive patients were less likely to quit and may particularly benefit from cessation support. Emphasizing smoking cessation with new or seropositive RA patients and leveraging health system interventions could improve smoking cessation and outcomes in RA.

Sleep Disorders in Connective Tissue Diseases—Coexisting Diseases or Disease Components?

“…Studies have consistently highlighted its detrimental effects on sleep quality, with smoking being associated with increased inflammation, a higher risk of SLE, accelerated radiographic progression in RA, and a worse response to MTX-based treatment [91][92][93][94]. Moreover, smoking is a common habit among RA patients, with nearly 26% being former smokers and around 14% current smokers [95]. Nicotine, a primary constituent of cigarettes, is strictly associated with sleep disturbances, with smokers generally exhibiting poorer sleep quality compared to non-smokers; in particular, night smokers experience pronounced sleep problems [96][97][98].…”

A New Reference Plasmid “pGMT27” Provides an Efficient Transgenic Detection Method for Flue-Cured Tobacco

“…According to the FAO (Food and Agriculture Organization) data, approximately 4 million hectares of lands are used for cultivating tobacco, one-third of which is in China alone [1]. As smoking is health related [2][3][4], consumers appear to have more cautious attitudes to tobacco than other crops and GM tobacco, as well as other GM crops.…”